Clinical Trial Update: Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical study assessing the combination of albumin-bound paclitaxel (nab-paclitaxel) and nedaplatin for cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Nedaplatin (nedaplatin)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Uterine Cervical Cancer | Phase 2 | Status: UNKNOWN